Vanguard Group’s Matinas BioPharma MTNB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.2K | Hold |
59,725
| – | – | ﹤0.01% | 4193 |
|
|
2025
Q1 | $31.1K | Sell |
59,725
-46,769
| -44% | -$24.3K | ﹤0.01% | 4223 |
|
|
2024
Q4 | $54.3K | Sell |
106,494
-79,863
| -43% | -$40.7K | ﹤0.01% | 4209 |
|
|
2024
Q3 | $660K | Sell |
186,357
-9,131,481
| -98% | -$32.3M | ﹤0.01% | 3901 |
|
|
2024
Q2 | $1.48M | Hold |
9,317,838
| – | – | ﹤0.01% | 3663 |
|
|
2024
Q1 | $2.53M | Hold |
9,317,838
| – | – | ﹤0.01% | 3517 |
|
|
2023
Q4 | $2.01M | Buy |
9,317,838
+564,020
| +6% | +$122K | ﹤0.01% | 3600 |
|
|
2023
Q3 | $1.14M | Buy |
8,753,818
+33,400
| +0.4% | +$4.34K | ﹤0.01% | 3787 |
|
|
2023
Q2 | $3.14M | Sell |
8,720,418
-39,742
| -0.5% | -$14.3K | ﹤0.01% | 3504 |
|
|
2023
Q1 | $4.12M | Buy |
8,760,160
+153,639
| +2% | +$72.2K | ﹤0.01% | 3394 |
|
|
2022
Q4 | $4.3M | Buy |
8,606,521
+176,347
| +2% | +$88.2K | ﹤0.01% | 3376 |
|
|
2022
Q3 | $5.36M | Buy |
8,430,174
+16,100
| +0.2% | +$10.2K | ﹤0.01% | 3291 |
|
|
2022
Q2 | $6.65M | Buy |
8,414,074
+529,155
| +7% | +$418K | ﹤0.01% | 3218 |
|
|
2022
Q1 | $6.34M | Sell |
7,884,919
-47,596
| -0.6% | -$38.3K | ﹤0.01% | 3405 |
|
|
2021
Q4 | $8.01M | Buy |
7,932,515
+51,414
| +0.7% | +$51.9K | ﹤0.01% | 3346 |
|
|
2021
Q3 | $10.2M | Buy |
7,881,101
+8,638
| +0.1% | +$11.2K | ﹤0.01% | 3227 |
|
|
2021
Q2 | $6.1M | Buy |
7,872,463
+20,613
| +0.3% | +$16K | ﹤0.01% | 3485 |
|
|
2021
Q1 | $8.24M | Buy |
7,851,850
+153,208
| +2% | +$161K | ﹤0.01% | 3255 |
|
|
2020
Q4 | $10.5M | Buy |
7,698,642
+77,512
| +1% | +$105K | ﹤0.01% | 2967 |
|
|
2020
Q3 | $5.84M | Hold |
7,621,130
| – | – | ﹤0.01% | 3076 |
|
|
2020
Q2 | $5.89M | Buy |
7,621,130
+46,600
| +0.6% | +$36K | ﹤0.01% | 3030 |
|
|
2020
Q1 | $4.55M | Buy |
7,574,530
+2,265,723
| +43% | +$1.36M | ﹤0.01% | 3006 |
|
|
2019
Q4 | $12.1M | Buy |
5,308,807
+126,911
| +2% | +$288K | ﹤0.01% | 2770 |
|
|
2019
Q3 | $3.27M | Buy |
5,181,896
+183,978
| +4% | +$116K | ﹤0.01% | 3281 |
|
|
2019
Q2 | $4.28M | Buy |
4,997,918
+1,419,118
| +40% | +$1.22M | ﹤0.01% | 3221 |
|
|
2019
Q1 | $3.9M | Buy |
3,578,800
+817,017
| +30% | +$891K | ﹤0.01% | 3222 |
|
|
2018
Q4 | $1.64M | Buy |
2,761,783
+228,450
| +9% | +$136K | ﹤0.01% | 3432 |
|
|
2018
Q3 | $2.33M | Sell |
2,533,333
-16,076
| -0.6% | -$14.8K | ﹤0.01% | 3475 |
|
|
2018
Q2 | $1.11M | Sell |
2,549,409
-234,750
| -8% | -$102K | ﹤0.01% | 3661 |
|
|
2018
Q1 | $2.13M | Buy |
2,784,159
+84,611
| +3% | +$64.7K | ﹤0.01% | 3439 |
|
|
2017
Q4 | $3.13M | Buy |
2,699,548
+63,916
| +2% | +$74.1K | ﹤0.01% | 3291 |
|
|
2017
Q3 | $3.48M | Buy |
2,635,632
+188,655
| +8% | +$249K | ﹤0.01% | 3241 |
|
|
2017
Q2 | $4.14M | Buy |
+2,446,977
| New | +$4.14M | ﹤0.01% | 3156 |
|